The global Drug Development Testing Services market size is predicted to grow from US$ 660 million in 2025 to US$ 993 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.
Drug development can be divided into four phases: discovery, preclinical studies, clinical development and market approval.The Drug Discovery Process involves many different stages and series of actions. Lab-based drug tests are more accurate. We like to say they are more rigorous, more involved, and more defensible in a court of law, all of which are elements certain organizations must consider, particularly heavily regulated industries, like the DOT.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The 鈥淒rug Development Testing Services Industry Forecast鈥� looks at past sales and reviews total world Drug Development Testing Services sales in 2024, providing a comprehensive analysis by region and market sector of projected Drug Development Testing Services sales for 2025 through 2031. With Drug Development Testing Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Development Testing Services industry.
This Insight Report provides a comprehensive analysis of the global Drug Development Testing Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Drug Development Testing Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drug Development Testing Services market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Development Testing Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Development Testing Services.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Development Testing Services market by product type, application, key players and key regions and countries.
Segmentation by Type:
In Vivo Services
Bio Chemistry Analytical
Microbiology Analytical
Others
Segmentation by Application:
Drug Development
Clinical Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Pacific BioLabs
Catalent
ICON
ProPharma Group
WuXi AppTec
Labcorp
MedPharm
Patheon
CTI
Thermo Fisher
ChemPartner
Frontage Labs
ChemDiv
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Development Testing Services Market Size (2020-2031)
2.1.2 Drug Development Testing Services Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Drug Development Testing Services by Country/Region (2020, 2024 & 2031)
2.2 Drug Development Testing Services Segment by Type
2.2.1 In Vivo Services
2.2.2 Bio Chemistry Analytical
2.2.3 Microbiology Analytical
2.2.4 Others
2.3 Drug Development Testing Services Market Size by Type
2.3.1 Drug Development Testing Services Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Drug Development Testing Services Market Size Market Share by Type (2020-2025)
2.4 Drug Development Testing Services Segment by Application
2.4.1 Drug Development
2.4.2 Clinical Research
2.4.3 Others
2.5 Drug Development Testing Services Market Size by Application
2.5.1 Drug Development Testing Services Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Drug Development Testing Services Market Size Market Share by Application (2020-2025)
3 Drug Development Testing Services Market Size by Player
3.1 Drug Development Testing Services Market Size Market Share by Player
3.1.1 Global Drug Development Testing Services Revenue by Player (2020-2025)
3.1.2 Global Drug Development Testing Services Revenue Market Share by Player (2020-2025)
3.2 Global Drug Development Testing Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Development Testing Services by Region
4.1 Drug Development Testing Services Market Size by Region (2020-2025)
4.2 Global Drug Development Testing Services Annual Revenue by Country/Region (2020-2025)
4.3 Americas Drug Development Testing Services Market Size Growth (2020-2025)
4.4 APAC Drug Development Testing Services Market Size Growth (2020-2025)
4.5 Europe Drug Development Testing Services Market Size Growth (2020-2025)
4.6 Middle East & Africa Drug Development Testing Services Market Size Growth (2020-2025)
5 Americas
5.1 Americas Drug Development Testing Services Market Size by Country (2020-2025)
5.2 Americas Drug Development Testing Services Market Size by Type (2020-2025)
5.3 Americas Drug Development Testing Services Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Development Testing Services Market Size by Region (2020-2025)
6.2 APAC Drug Development Testing Services Market Size by Type (2020-2025)
6.3 APAC Drug Development Testing Services Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Development Testing Services Market Size by Country (2020-2025)
7.2 Europe Drug Development Testing Services Market Size by Type (2020-2025)
7.3 Europe Drug Development Testing Services Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Development Testing Services by Region (2020-2025)
8.2 Middle East & Africa Drug Development Testing Services Market Size by Type (2020-2025)
8.3 Middle East & Africa Drug Development Testing Services Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Development Testing Services Market Forecast
10.1 Global Drug Development Testing Services Forecast by Region (2026-2031)
10.1.1 Global Drug Development Testing Services Forecast by Region (2026-2031)
10.1.2 Americas Drug Development Testing Services Forecast
10.1.3 APAC Drug Development Testing Services Forecast
10.1.4 Europe Drug Development Testing Services Forecast
10.1.5 Middle East & Africa Drug Development Testing Services Forecast
10.2 Americas Drug Development Testing Services Forecast by Country (2026-2031)
10.2.1 United States Market Drug Development Testing Services Forecast
10.2.2 Canada Market Drug Development Testing Services Forecast
10.2.3 Mexico Market Drug Development Testing Services Forecast
10.2.4 Brazil Market Drug Development Testing Services Forecast
10.3 APAC Drug Development Testing Services Forecast by Region (2026-2031)
10.3.1 China Drug Development Testing Services Market Forecast
10.3.2 Japan Market Drug Development Testing Services Forecast
10.3.3 Korea Market Drug Development Testing Services Forecast
10.3.4 Southeast Asia Market Drug Development Testing Services Forecast
10.3.5 India Market Drug Development Testing Services Forecast
10.3.6 Australia Market Drug Development Testing Services Forecast
10.4 Europe Drug Development Testing Services Forecast by Country (2026-2031)
10.4.1 Germany Market Drug Development Testing Services Forecast
10.4.2 France Market Drug Development Testing Services Forecast
10.4.3 UK Market Drug Development Testing Services Forecast
10.4.4 Italy Market Drug Development Testing Services Forecast
10.4.5 Russia Market Drug Development Testing Services Forecast
10.5 Middle East & Africa Drug Development Testing Services Forecast by Region (2026-2031)
10.5.1 Egypt Market Drug Development Testing Services Forecast
10.5.2 South Africa Market Drug Development Testing Services Forecast
10.5.3 Israel Market Drug Development Testing Services Forecast
10.5.4 Turkey Market Drug Development Testing Services Forecast
10.6 Global Drug Development Testing Services Forecast by Type (2026-2031)
10.7 Global Drug Development Testing Services Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Drug Development Testing Services Forecast
11 Key Players Analysis
11.1 Pacific BioLabs
11.1.1 Pacific BioLabs Company Information
11.1.2 Pacific BioLabs Drug Development Testing Services Product Offered
11.1.3 Pacific BioLabs Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Pacific BioLabs Main Business Overview
11.1.5 Pacific BioLabs Latest Developments
11.2 Catalent
11.2.1 Catalent Company Information
11.2.2 Catalent Drug Development Testing Services Product Offered
11.2.3 Catalent Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Catalent Main Business Overview
11.2.5 Catalent Latest Developments
11.3 ICON
11.3.1 ICON Company Information
11.3.2 ICON Drug Development Testing Services Product Offered
11.3.3 ICON Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 ICON Main Business Overview
11.3.5 ICON Latest Developments
11.4 ProPharma Group
11.4.1 ProPharma Group Company Information
11.4.2 ProPharma Group Drug Development Testing Services Product Offered
11.4.3 ProPharma Group Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 ProPharma Group Main Business Overview
11.4.5 ProPharma Group Latest Developments
11.5 WuXi AppTec
11.5.1 WuXi AppTec Company Information
11.5.2 WuXi AppTec Drug Development Testing Services Product Offered
11.5.3 WuXi AppTec Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 WuXi AppTec Main Business Overview
11.5.5 WuXi AppTec Latest Developments
11.6 Labcorp
11.6.1 Labcorp Company Information
11.6.2 Labcorp Drug Development Testing Services Product Offered
11.6.3 Labcorp Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Labcorp Main Business Overview
11.6.5 Labcorp Latest Developments
11.7 MedPharm
11.7.1 MedPharm Company Information
11.7.2 MedPharm Drug Development Testing Services Product Offered
11.7.3 MedPharm Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 MedPharm Main Business Overview
11.7.5 MedPharm Latest Developments
11.8 Patheon
11.8.1 Patheon Company Information
11.8.2 Patheon Drug Development Testing Services Product Offered
11.8.3 Patheon Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Patheon Main Business Overview
11.8.5 Patheon Latest Developments
11.9 CTI
11.9.1 CTI Company Information
11.9.2 CTI Drug Development Testing Services Product Offered
11.9.3 CTI Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 CTI Main Business Overview
11.9.5 CTI Latest Developments
11.10 Thermo Fisher
11.10.1 Thermo Fisher Company Information
11.10.2 Thermo Fisher Drug Development Testing Services Product Offered
11.10.3 Thermo Fisher Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Thermo Fisher Main Business Overview
11.10.5 Thermo Fisher Latest Developments
11.11 ChemPartner
11.11.1 ChemPartner Company Information
11.11.2 ChemPartner Drug Development Testing Services Product Offered
11.11.3 ChemPartner Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.11.4 ChemPartner Main Business Overview
11.11.5 ChemPartner Latest Developments
11.12 Frontage Labs
11.12.1 Frontage Labs Company Information
11.12.2 Frontage Labs Drug Development Testing Services Product Offered
11.12.3 Frontage Labs Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.12.4 Frontage Labs Main Business Overview
11.12.5 Frontage Labs Latest Developments
11.13 ChemDiv
11.13.1 ChemDiv Company Information
11.13.2 ChemDiv Drug Development Testing Services Product Offered
11.13.3 ChemDiv Drug Development Testing Services Revenue, Gross Margin and Market Share (2020-2025)
11.13.4 ChemDiv Main Business Overview
11.13.5 ChemDiv Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
